Climb Bio CLYM
NASDAQ CLYM
$11.50 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:59 PM EDT

Climb Bio (CLYM) EV to CFO (2024)

Updated

Climb Bio's (CLYM) EV to CFO was -129.03 for Q2 2024.

Analysis

Climb Bio (CLYM) EV to CFO (2024) Analysis & Trends

Over the twelve months ended Jun 30, 2024, Climb Bio's EV to CFO came in at -5730.12.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Climb Bio 875.77 Mn 875.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -129.03
API Access

Climb Bio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CLYM&period=max&api_key=YOUR_API_KEY